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Chapter One: Introduction
Goals of Current Research
The present study sought to elucidate upon the paucity of findings
currently available with regard to age-related differences in parvalbumin (PV)
expression across brain regions and the septotemporal axis of the hippocampus
(HPC) in rats. The lack of available information regarding normative distribution
of this calcium binding protein is surprising, given the multitude of studies
demonstrating: 1) decreased distribution of PV-expressing GABAergic neurons in
post-mortem tissue from schizophrenic patients, and 2) a decrease in PVexpressing GABAergic neurons in forebrain tissue subsequent to acute and
chronic NMDA antagonist treatment (e.g., Kittelberger et al., 2012; Wang et al.,
2008; Abekawa et al., 2007; Braun et al., 2007; Keilhoff et al., 2004). The latter of
which is a widely used model to examine the neuropathological events, as well
as the altered behavior/cognitive processes, seen in schizophrenia.
In chapter one, we provide context for the current study, first with a
description of the features of schizophrenia and the anatomical changes
observed in post-mortem human brain tissue. Secondly, we discuss the
importance of observed changes in local circuit GABAergic neurons, and define
the anatomical and morphological features of key GABAergic cell populations.
Lastly, we discuss the literature regarding treatment- and age-related changes in
PV expressing neuron populations.

1

Schizophrenia
Schizophrenia is a complex psychological disorder affecting approximately
1% of the population worldwide (Perälä et al., 2007). The illness is characterized
by positive symptoms including hallucinations, delusions, and paranoia; negative
symptoms which include social deficits and flattened affect; and, of particular
note, cognitive symptoms which can manifest as marked deficits in attention and
memory (Lewis & Lieberman, 2000; Gold, 2004). Currently, positive and, to a
certain extent, negative symptoms can be managed through pharmacological
treatment with antipsychotic medication such as haloperidol, risperidone, and
clozapine, to name a few (Carman et al., 1995; Leucht et al., 2009). However,
there are no antipsychotic pharmaceutical interventions capable of mediating the
debilitating cognitive deficits characteristic of schizophrenia (Buchanan et al.,
2007). Within the past two decades, there has been a concerted effort to
understand the underlying etiology of cognitive deficits in schizophrenia. In order
to better understand these deficits, and thus foster development of novel
cognitive-targeting interventions, it would be helpful to establish a more
comprehensive understanding of the neurobiology of forebrain circuits that
support the cognitive processes which are altered in schizophrenia.
There are many theories regarding the etiology of schizophrenia,
including, but not limited to: genetic predisposition ( Bergen & Petryshen, 2012;
Kukshal et al., 2012; Owen, 2012; Greenwood et al., 2013), prenatal infection
(Brown & Derkits, 2009; Brown & Patterson, 2011), environmental influence (van
Os et al, 2010; Bourque et al., 2012), as well as a large body of evidence
2

supporting combinations of the aforementioned (e.g. Clarke et al., 2009;
Holtzman et al, 2012; Pelayo-Terván et al., 2012). However, it is clear from
imaging and postmortem studies that distinct anatomical changes – including:
volumetric (Bogerts et al, 1985; Honea et al., 2005; Haijma et al, 2012), circuitry
(Lewis & Sweet, 2009; Uhlhaas & Singer, 2010), connectivity (Camchong et al.,
2011; Schmitt et al., 2011), and neuronal (Harrison, 1999) - contribute to the core
cognitive dysfunction in schizophrenia. Importantly, forebrain circuitry, including,
but not limited to, prefrontal cortex and temporal lobe structures, are found to
have altered regional activity (e.g. magnetic resonance imaging; Shenton et al.,
2001; Schobel et al., 2009), differences in white matter connections (e.g.
diffusion tensor imaging; Kubicki et al., 2007), and regionally specific volumetric
decreases (Sigmundsson et al., 2001) in schizophrenic patients as compared to
healthy controls.

Circuitry Implicated in Schizophrenic Cognitive Dysfunction

Cognitive dysfunction is pervasive throughout the lifetime of schizophrenic
patients, and severity of cognitive deficits is independent of other psychotic
symptoms, and even predictive of prognosis (Tamminga et al., 1998). Much
emphasis has been placed on the decreased ability of patients to complete
working memory tasks, particularly those involving a high degree of information
manipulation (Barch, 2006). Dorsolateral prefrontal cortical (DLPFC) circuitry is
implicated in these working memory deficits, and studies of working memory in
schizophrenics have even demonstrated an alterations in DLPFC activation in
3

patients during working memory tasks (Tan et al., 2007). Additionally,
hippocampal circuitry, as well as hippocampal-cingulate cortical circuit systems,
is thought to be altered at both macro- (e.g. regional interconnections) and micro(e.g. local inhibition onto pyramids) levels (Benes, 2000). Within these circuits,
we are particularly interested in changes seen in GABAergic local circuit
networks, as they play a critical role in regulating cognitive and memory
processes (Buzsaki & Chrobak, 1995). Furthermore, evidence suggests that
there are evolutionary changes within select GABAergic neurons within the
forebrain contribute to developmental alterations in cortical and hippocampal
macro- and micro-circuits (Hof et al., 1999; Burns, 2004). These alterations can
manifest as cognitive dysfunction in a number of psychiatric disorders (e.g.,
schizophrenia, autism, Alzheimer’s; Raghanti et al., 2010).
Alterations in activation seen during neuroimaging studies in DLPFC are
likely due to dysfunctional neuronal activity. Specifically, a decrease in
GABAergic neurotransmission, and consequently decreased inhibition of
excitatory pyramidal neurons, and conversely, even increased inhibition due to
compensatory up-regulation of GABA receptors (Gonzalez-Burgos & Lewis,
2008), have been described (Volk & Lewis, 2002; Lisman et al., 2008). Of
particular note, the selective decrease of PV-expression within inhibitory
GABAergic interneurons, especially within prefrontal cortex and hippocampus, is
thought to play a key role in these observed alterations (Lewis et al., 1999;
Hashimoto et al., 2003; Lewis et al., 2004). Disrupted signaling within this circuit
is likely the driving force behind these deficits, and therefore inhibitory
4

interneurons are being considered as targets for possible cognitive-enhancing
treatments (Lewis et al., 2005).
Afferent and efferent connections between the DLPFC and hippocampus
are also thought to be altered, thereby contributing to deficits seen during
cognitive processes that require the manipulation and temporal and/or spatial
encoding of information (Meyer-Lindenberg et al., 2005). Furthermore, local
inhibitory circuitry within the hippocampus has been found to be altered at the
synaptic level (e.g. aberrant functionality and synaptic connections) and
contributes to widespread cognitive dysfunction (Harrison, 2004). The GABAergic
alterations within the prefrontal cortex and hippocampus are further implicated in
post-mortem studies of schizophrenic brains, where immuno-reactive labeling
studies reveal a selective reduction of the calcium-binding protein parvalbumin,
relative to controls (Beasley & Reynolds, 1997; Zhang & Reynolds, 2002). While
there is a selective reduction in PV-expressing GABAergic neurons, there is no
concurrent decrease in either calretinin or calbindin populations (Zhang &
Reynolds, 2002; Lewis et al., 2012). Why forebrain PV-expressing GABAergic
neurons would be selectively disrupted is unclear, although evidence presented
in the current study suggest developmental changes in PV expression that
perhaps make these neurons vulnerable to dysfunction.

5

GABAergic Inhibitory Interneurons
GABAergic interneurons are integral for optimal functioning within the
brain, and play important roles in regulating neurotransmission and coordinating
concerted neuronal ensembles (Buzsaki & Chrobak, 1995). These interneurons
can be divided into various subtypes, often by the calcium-binding proteins they
express (McBain & Fisahn, 2001). Within the brain, there are many different
populations of inhibitory interneurons expressing calcium-binding proteins, some
of which are used as cellular markers, including: calbindin, calmodulin, calretinin,
and parvalbumin (Freund & Buzsaki, 1996; Markram et al., 2004). These
calcium-binding proteins allow for the binding and intracellular transportation of
calcium ions and can differentially affect the temporal dynamics of cellular
function post stimulation (Arif, 2009).

Parvalbumin-Expressing Interneurons

Parvalbumin-positive interneurons are widespread throughout the brain
and can be subdivided by their morphological characteristics, as well as their
laminar and anatomical locations (Freund & Buzsaki, 1996; Hof et al., 1999). PV
protein is primarily expressed in three distinct GABAergic interneuron subtypes:
basket cells, chandelier cells (in neocortex; referred to as bistratified cells in
HPC), and O-LM cells (in stratum oriens in HPC) (Freund & Buzsaki, 1996;
Klausberger, 2009). Chandelier cells are primarily located in cortical layers II-VI,
as well as within the hippocampus (though here they are often referred to as axoaxonic or bistratified cells), and have axonal terminations exclusively on the axon
6

initial segment of excitatory pyramidal neurons (Markram et al, 2004). Though
there are relatively few of this cell type compared to other inhibitory interneurons,
these are thought to be very powerful with regard to their ability to regulate neural
transmission in the brain (Woodruff et al., 2010). Due to their inhibition directly
onto the axon initial segment, chandelier cells also play an important role in
regulating pyramidal cell excitatory output (Lewis et al., 2004); specifically, the
ability for a single chandelier cell to target large populations of pyramidal neurons
allows for wide-spread synchronization of excitatory transmission (Cobb et al.,
1995).
Basket cells, which are located within the cortex, hippocampus, and
cerebellum (Seto-Ohshima et al., 1989), synapse onto pyramidal cell somata and
proximal dendrites and are primarily located within the pyramidal and granule cell
layers in the hippocampus (Nitsch et al., 1990; Freund & Buzsaki, 1996). Like
chandelier cells, a single parvalbumin-containing basket cell is able to make a
large number of connections onto local pyramidal neurons, as well as synapsing
with other parvalbumin-containing interneurons (Sik et al, 1995), thereby giving
these interneurons the ability to strongly modulate postsynaptic excitatory output
(Aradi et al., 2002). PV expressing cells are also located outside of the pyramidal
and granule cell layers within stratum oriens, where these PV-expressing
interneurons are referred to as O-LM cells, as well as in the hilus (Sloviter, 2004).
Within the CA1 region of the hippocampal formation, basket cells and
chandelier cells make up approximately 75% of the total interneuron population
(Szilagyi et al., 2011). The anatomical distribution of parvalbumin-positive
7

inhibitory interneurons within each sub-area of the hippocampus (CA1, CA3,
dentate gyrus) appears to have consistent laminar profiles across the dorsoventral axis, as well as no dorso-ventral differences in expression within each
hippocampal area, at least in the rat (Kosaka et al, 1987; Nomura et al, 1997a;
1997b).

Treatment and Age-Related Changes in Parvalbumin
Expression

Of particular relevance to the selective decrease in PV expressing
interneurons within schizophrenic postmortem tissue, have been studies
employing acute and/or chronic NMDA-antagonist drug regimens in rodents (e.g.
Kittelberger et al., 2012). While such studies have generally reported a decrease
in PV as a result of NMDA-antagonist administration (e.g. Romon et al., 2011;
Wang et al., 2008; Braun et al., 2007; Keilhoff et al., 2004), there have been
some studies indicating no change in PV-immunoreactivity following drug
administration (e.g. Benneyworth et al., 2011; Zhang et al., 2008). What is
interesting regarding these conflicting findings is that the studies do not control
for age as a possible factor influencing PV expression. Rather, many of these
studies seem to assume stability in PV expression over the lifespan. A major
rationale for the current studies was to examine age-related differences in PV
expression so as to better understand the existing literature and inform future
studies on the effects of chronic NMDA-antagonist treatments.
Age-related changes in parvalbumin expression have been found in
cortical (Ouda et al., 2008), as well as subcortical areas including the
8

hippocampus (Vela et al., 2003). However, there have been very few studies
offering conclusive findings outlining age-dependent changes in hippocampal PV
expression in a systematic way. In fact, to our knowledge, only a few studies
have been conducted seeking to directly compare PV expression in young and
aged rats in an attempt to characterize calcium-binding protein distribution as a
function of age(e.g. Shetty & Turner, 1998; Vela et al., 2003; Stanley et al.,
2012). Though there have been few studies, Shetty and Turner (1998) describe
significant decreases in PV immunoreactivity within HPC CA1, CA3, and hilus
between 5- and 24-month old rats, and these findings are in agreement with the
limited work conducted across portions of the rat lifespan (Vela et al., 2003;
Stanley et al., 2012).
The lack of systematically conducted normative baseline data regarding
PV distribution across the lifespan is concerning, especially considering that
rodent studies examining PV expression rarely account for the age of the animals
used. This is evident in a study conducted by Nomura and colleagues (1997a)
reporting no changes in hippocampal PV expression. Though they looked both
between hippocampal regions and across the septotemporal axis, their data was
exclusively collected from 5 week old rats, and therefore should not be
generalized as a stable property of PV distribution across all age groups.
Furthermore, the lack of baseline data makes it difficult to make conclusions
based on data derived from experiments utilizing drug manipulations, as PV
immunoreactivity may be dynamically altered based on a variety of endogenous
and exogenous factors including, but certainly not limited to, age and experience.
9

The current study aimed to provide the first systematic characterization of
PV-expression within the hippocampus, as well as within somatosensory and
limbic cortices. In order to address the lack of data on normative PV distribution
we set out to determine the following things with regard to PV immunoreactivity in
young, adult, and aged rats: 1) whether PV expression differs along the
septotemporal axis of the hippocampus; 2) whether or not PV exhibits an agedependent profile of distribution and to determine whether our findings were
consistent with the few studies which have also looked at age as a key factor;
and 3) whether PV expression varies as a function of hippocampal sub-region
(CA1, CA3, and DG), as well as cortical region (somatosensory and limbic
cortices). The current study provides key normative data to inform future studies
employing experimental manipulations, and allows for a more dynamic view of
PV as a neural marker for pathology.
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Chapter Two: Manuscript
Abstract
Parvalbumin (PV)-expressing inhibitory interneurons are the most numerous
GABAergic interneuron type in the neocortex and hippocampus (HPC). Selective
reductions in PV interneurons are observed in cortical and limbic regions in
postmortem human schizophrenic brain tissue. Reductions in PV expression are
also observed in rodents following acute and/or chronic treatment with NMDAantagonists (e.g. ketamine). There are inconsistencies in the literature regarding
age-related changes in PV expression in the HPC; some stating age-related
decreases, no observed changes, and even increases in PV-immunoreactivity.
These inconsistencies make it difficult to qualitatively and quantitatively evaluate
changes observed in rodent models following NMDA-antagonist treatment. In
order to provide a better baseline understanding of putative developmental
changes in normal PV expression, the current study quantified 1) age-related
changes in HPC and cortical PV expression in rats; 2) whether PV varied along
the septotemporal axis of the HPC; and 3) regional changes in HPC PV
expression. PV immunohistochemical methods were used to examine PV
expression in hippocampal and adjacent neocortical regions in 1 and 6 month old
naïve, as well as 24 month old behaviorally trained (radial water maze training),
male Sprague-Dawley rats. Our main findings include: 1) specific regional
differences (CA1, CA3, DG) across the septotemporal axis that varied by
developmental age; 2) age-related decreases in PV expression in CA1 and DG
(50-68% and 88-89% decrease from 1 – 6 months, respectively) in naïve rats;
11

and 3) A prominent increase in PV expression in the 24 month old rats that may
be related to age or behavioral experience. These findings demonstrate
developmental differences in the regional expression of PV, as well as potential
behavioral and experiential increases in PV expression. Importantly, these
baseline data provide key information for future work examining age-related
differences in PV as a consequence of acute or chronic NMDA-antagonist
treatment.

12

Introduction
A consistent finding in post-mortem schizophrenic brain tissue has been a
selective reduction in a subset of inhibitory GABAergic interneurons containing
the calcium-binding protein parvalbumin (PV) (Beasley & Reynolds, 1997; Volk et
al., 2012; Lewis et al., 2012). PV-containing interneurons provide critical
inhibition onto the soma and proximal dendrites of excitatory pyramidal neurons
(Zuschratter et al., 1985; Kawaguchi et al, 1987; Katsumaru et al, 1988; Williams
et al., 1992), which allows them to play a key role in determining the excitatory
output of their postsynaptic targets (Lewis et al., 2004). This role likely
contributes to the ability for involved neuronal circuits to accurately relay relevant
information and support neural circuit processes key to cognitive function.
Because of their importance in neocortical and hippocampal neuronal circuitry,
the decrease in PV interneurons seen in schizophrenic brains likely contributes to
the cognitive dysfunctions observed in schizophrenia.
Research of the underlying etiology of schizophrenia is difficult, as postmortem human tissue can be confounded by countless variables (e.g.,
medication, co-morbid illnesses, drug use, etc.). Therefore, rodent models have
been integral in enhancing our understanding of the proposed neural
mechanisms underlying the disorder. A multitude of rodent models exist for the
study of schizophrenia, ranging from genetic knockout mice (Chen et al., 2006),
social isolation (Stevens et al., 1997), post-natal (Wedzony et al., 2008) or adult
drug administration (Egerton et al., 2005; Chrobak et al., 2008), and even those
employing a “two-hit” model consisting of two separate insults over the lifespan
13

(e.g., Bayer et al., 1999; Corriveau & Glenn, 2012). Of particular interest are
rodent models exhibiting NMDA-antagonist induced selective reductions in PV
expression in key brain regions such as prefrontal cortex and hippocampus
(Keilhoff et al., 2004; Morris et al., 2005; Abekawa et al., 2007; Zhang et al.,
2008). However, these findings often lack consistency, with some researchers
indicating no changes in PV expression (Benneyworth et al., 2011), and other
reports indicating exactly the opposite findings of one another (see Benneyworth
et al., 2006; table 3). Alarmingly, there have been few studies providing
consistent information regarding what could be considered ‘normal’ with regard to
PV distribution within rodent brains, and whether the changes we are seeing are
truly representative of human schizophrenic pathology.
In order to better understand the normative distribution of PV interneurons
throughout the brain in rodents, and to establish a baseline of PV distribution
consistent with past findings, we conducted a series of immunohistological
studies in rats to visualize PV expression in cortical and hippocampal areas. We
also quantified PV expression across the rat lifespan (specifically in postweaning, young adult, and aged cohorts) within the brain regions of interest, as
there are mixed reports indicating a decline in PV expression in some (Lolova &
Davidoff, 1992; Miettinen et al., 1993), but not all (e.g., Vela et al., 2003; Potier et
al., 2006), age-related PV studies. The current study also looked across the
septotemporal axis of the hippocampus across aging, as there have been no
studies, to our knowledge, that have systematically examined changes in PV
expression in such a way. Here, we provide compelling evidence for an age14

dependent reduction of PV expression across hippocampal areas, as well as
age-dependent septotemporal variation in PV expression. Furthermore, we
provide evidence suggesting a role for behavioral enrichment in increasing PV
expression within the rodent brain. Overall, our findings support a dynamic role
of PV expression across the rat lifespan, particularly within the hippocampus and,
to a lesser degree, within adjacent limbic cortex and neocortical regions.

Materials and Methods
Animals

Twenty-six male Sprague Dawley rats (Charles River Laboratories,
Wilmington, MA) spanning three different ages were used: adolescent
(approximate age P30; referred to as 1 month old; n = 8), young adult
(approximate age P120-180, referred to as 6 month old; n = 8), and aged (24
months old, n = 8). Young adult and aged rats were single-housed, while
adolescent rats were housed in groups of four, in clear polycarbonate caging.
Normal husbandry procedures were followed for all rats within a temperature and
humidity controlled vivarium, with a 12-hour light/dark cycle (lights on at 0800h),
with access to food and water ad libitum. Additional animals were used to
optimize Parvalbumin (PV) antibody concentration prior to immunohistochemical
processing of experimental tissue (n = 2).
Young (1 month) and adult (6 month) rats were experimentally naïve,
while aged (24 month) rats had a history of behavioral testing (continuous radial
15

water maze experience from approx. P60 – 1.5 years of age; details of training
can be found in Chrobak et al., 2008) and pharmacological testing (ketamine and
cannabinoid antagonist treatments from 1-1.5 years of age). Additionally, aged
rats had restricted food intake strictly during behavioral testing. However, all
behavioral and pharmacological manipulations were completed minimally four
months prior to sacrifice/brain collection. All housing and experimental
procedures were in accordance with, and approved by, the University of
Connecticut Institutional Animal Care and Use Committee.

Immunohistochemistry

All rats were anesthetized with Euthasol (pentobarbital sodium solution;
1mL via intraperitoneal injection) and transcardially perfused first with ice-cold
.9% physiological saline solution (approximately 200mL for 5 minutes), followed
by ice-cold 3.7% paraformaldehyde solution (approximately 200mL for 5 min).
Brains were removed and stored in 3.7% paraformaldehyde solution prior to
being cryoprotected in a 30% sucrose solution for 48 hours before being sliced
into 60µm coronal sections on a cryostat. Sections were taken from
approximately -2.5mm through -6.0mm relative to Bregma (Paxinos & Watson,
1997; see Figure 1) that included distinct septotemporal areas of the HPC as well
as adjacent cortical areas (retrosplenial and somatosensory), and then stored in
phosphate-buffered saline (PBS)-containing well plates.
One series of tissue slices (each sample roughly separated by 240µm) per
brain were selected to examine Parvalbumin (PV) immunoreactivity (n=24
16

series). Free-floating sections were initially blocked in 5% normal goat serum
(Jackson Immuno), 0.1% triton-X, and PBS solution for 1h, followed by 3 fiveminute rinses in PBS. Sections were then transferred into primary antibody
solution (1:4000 anti-rabbit parvalbumin antibody (Calbiochem), 0.1% triton-X,
and PBS – antibody concentration determined previously using aged rat brains
(n=2) (see Figure 2)) for a 24h incubation period at room temperature. Sections
were then rinsed 3 times at 5 minutes, and transferred into secondary solution
(HRP labeled polymer anti-rabbit, DAKO) for a 2h room-temperature incubation
period. Following a final set of 3 five-minute rinses in PBS, sections were
transferred into a diaminobenzidine (DAB) chromogen solution (DAKO;
Carpinteria, CA) for ten minutes to develop the stain. Sections were mounted and
dried on glass slides, then cover-slipped for microscopy using DPX. Adjacent
sections were processed for Nissl body staining using thionin to assist with
identification of brain regions.

Data Analysis

A Nikon Eclipse E600 (Melville, NY) upright microscope equipped with an
Insight SPOT digital camera (Diagnostic Instruments, Inc.) was used to examine
and photograph sections with the assistance of SPOT software (SPOT Imaging
Solutions; Sterling Heights, MI). Sections containing the major hippocampal
subdivisions (CA1, CA3, and DG) were selected for analysis along the
septotemporal axis within -2.45mm through -3.9mm (septal regions) and within 5mm through -6mm (midseptotemporal and temporal regions) relative to Bregma
17

(Steullet et al., 2010; Nomura et al., 1997a); see Figure 1 for section selection.
Additionally, photomicrographs were taken of retrosplenial and somatosensory
(barrel field) cortices, sampled from sections containing septal hippocampus, and
were digitally catalogued for later analysis (see Figure 10A). Hippocampal subregions and retrosplenial cortex were photographed at 10x magnifications, while
neocortical areas were photographed at 4x magnification to ensure inclusion and
visualization of all cortical layers.
Digital photographs were analyzed using ImageJ software (NIH), and the
number of PV immunoreactive interneurons was quantified using macros written
to automate particle counting within each specified region. The sizes of the
analyzed regions were as follows: CA1/CA3/ DG, 800µm x 500µm; retrosplenial
cortex, 800µm x 800µm; somatosensory, 1600µm x 1000µm. Sections were
chosen for analysis based on their anatomical location; representative
photomicrographs containing septal CA1, CA3, and DG, were taken from levels
corresponding to -2.45mm to -3.9mm relative to Bregma (Figure 3A);
midseptotemporal and temporal CA1, CA3, and DG were taken from levels
corresponding to -5.0mm to -6.0mm relative to Bregma (Figure 3B) (Paxinos &
Watson, 1997). The average PV immunoreactivity, as counted using ImageJ
macro parameters (see Figure 4), for each counted region was averaged for
each age group to determine whether there were differences across hippocampal
regions and/or across the long axis, in addition to possible differences within
neocortical regions. Regional and areal differences in the distribution of PV+
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interneurons were assessed using one-way Analysis of Variance (ANOVA)
followed by post-hoc t-tests (Kirk, 2012).

Results
Summary of Results

Overall, data indicated an age (1-, 6-, and 24-month), regional (cortical
field, hippocampus), septotemporal (septal, midseptotemporal, temporal), and
hippocampal region (CA1, CA3, DG) variation in the distribution of PV-expressing
interneurons. First, we will describe the differences in PV expression across the
septotemporal axis within the hippocampal subdivisions when comparing 1- and
6-month old rat brain tissue. In 6 month old rats, there was a significant
difference in PV expression from septal to temporal CA1 and DG (50- 80%
decrease in expression from septal to temporal regions). Second, we describe
the age-dependent differences in PV expression observed within specific
hippocampal subdivisions. Generally, there were significant decreases in the
number of PV expressing neurons in the CA1 and DG regions of 6-month,
compared to 1-month, old rats without concomitant changes within the CA3 subregion. No differences were observed in the two neocortical fields from the same
septal coronal sections (barrel field and retrosplenial cortices). Third, we describe
the regional (CA1, CA3, DG) differences in PV expression, where there is,
generally, a higher density of PV+ interneurons observed in CA1 sub-regions in
contrast to CA3 or DG. Lastly, we report a striking increase in PV expression in
all regions of interest (cortical areas and hippocampal regions) in the 24-month
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old age group, compared to 6-month old rats. Notably, this effect is confounded
by the extensive behavioral training that the 24-month old rats received. Ongoing
experiments are being conducted to determine whether these differences are
consequent of age and/or experience.

Age-related septotemporal variation in HPC parvalbumin expression

There was no difference in the distribution of PV expressing neurons
across the septotemporal axis of CA1, CA3, or the DG in 1 month and 24 month
old rats (see Figure 5). In contrast, 6-month old rats exhibit a significant effect of
septotemporal location in CA1 and DG. Specifically, septal CA1 in 6 month old
rats had significantly greater PV expression than both midseptotemporal and
temporal CA1 (F(2, 14) = 21.4, p < .001; see Figure 5A). Similarly, septal DG in
6-month old rats had significantly greater PV expression than the
midseptotemporal region (F(1, 7) = 6.5, p < .05; see Figure 5B). In contrast, there
were no septotemporal variations in region CA3 of the hippocampus (F(2, 14) =
3.3, p = .07; see Figure 5C). For representative photomicrographs of CA1, CA3,
and the DG, see Figures 6, 7, and 8 (respectively); descriptive statistics can be
seen in Table 1.

1- to 6-months: Age-related difference in regions CA1 and DG that
increases with difference from septal pole

Overall, there was a similar expression of PV in region CA3 in 1 and 6
month old rats across all septotemporal levels, however, there was less PV in
20

more temporal levels in both CA1 and the DG. Specifically, there was an agedependent decrease in PV expression within CA1, such that 1-month old rats
had significantly higher PV expression than 6-month old rats in midseptotemporal
(t(14) = 3.3, p < .01) and temporal levels (t(13) = 3.8, p < .01), though there was
no difference between these groups in septal CA1 t (p = .24); see Figure 9A.
There was also an age-dependent decline in PV expression in both septal DG
(t(14) = 7.1, p < .001) and midseptotemporal DG (t(12) = 2.4, p <.05), see Figure
9B. However, no age-related differences in PV expression were observed in
septal (p = .11), midseptotemporal (p = .66), or temporal (p = .47) CA3 (Figure
9C). These data can be visualized in representative photomicrographs in Figures
6, 7, and 8. No significant age-related effects were seen in retrosplenial (p = .52;
Figure 10B) or barrel field (p = .28; Figure 10C) cortices between 1- and 6-month
old naïve rats (Representative photomicrographs in Figures 11 and 12).
Descriptive statistics can be seen in Table 1.

CA1 regions have increased PV expression compared to other HPC
regions across all age groups

Significant regional differences in PV expression were seen in septal and
midseptotemporal, but not temporal, hippocampal regions across all age groups
(1-, 6-, and 24-months). 1-month old rats have significantly higher PV expression
in septal CA1 compared to septal CA3 (p < .01) and DG (p < .001).
Midseptotemporal sections follow the same pattern, with CA1 having significantly
more PV expression than CA3 (p < .001) and DG (p < .001). 6-month old rats
had significantly higher PV expression in septal CA1 in comparison to septal CA3
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(p < .001) and DG (p < .001), in addition to having significantly higher PV
expression in midseptotemporal CA1 compared to both midseptotemporal CA3
(p < .05) and DG (p < .01). In 24-month old extensively trained rats, septal CA1
had significantly higher PV expression than septal CA3 (p < .01) and DG (p <
.001). Interestingly, in midseptotemporal regions, CA1 and CA3 were not
significantly different from one another (p = .25), but both had higher PV
expression than midseptotemporal DG (p < .01, p < .05; respectively). These
data can be seen in Figure 13, and descriptive statistics can be seen in Table 1.

Increased parvalbumin expression in 24-month old extensively
trained rats across all hippocampal and cortical regions examined

A striking increase in PV expression was observed in 24-month old
extensively trained rats relative to 1- and 6-month old naïve rats within all
hippocampal and cortical regions quantified. There was significantly more PV
expression in both retrosplenial and barrel field cortices in 24- compared to 1- (p
< .05, p < .001; respectively) and 6- (p < .05, p < .001; respectively) month old
rats (Figure 10). 24-month old rats had significantly higher PV expression than 6month old rats in all hippocampal regions observed: Septal CA1 (p < .05), CA3 (p
< .05), and DG (p < .001); midseptotemporal CA1 (p < .01), CA3 (p < .01), and
DG (p < .05); and temporal CA1 (p < .001) and CA3 (p < .01). 24-month old rats
had significantly higher PV expression than 1-month old rats in midseptotemporal
(p < .05) and temporal (p = .01) CA3, but these two age-groups had statistically
equivalent PV expression in all other hippocampal regions observed (p’s > .1).
These data can be seen more clearly in Figure 14, and Table 1.
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Discussion
Understanding the normative distribution of a target cellular population - in
this case PV expressing GABAergic interneurons - is integral to the interpretation
and understanding of data derived from experimental manipulations (e.g.,
pharmacological, trauma, etc.) in rodent models of psychiatric disorders.
Currently, there is a significant lack of normative baseline knowledge of PV
expression across the hippocampal septotemporal axis as a function of aging.
The current data decreases the paucity of data in this regard and should
contribute to future evaluations of PV loss consequent to experimental
manipulations. Importantly, we provide compelling evidence of an age-dependent
decline in PV expression that varies with respect to hippocampal region (CA1,
CA3, and the DG), as well as across the septotemporal axis. Furthermore, we
present evidence that PV expression may be more dynamic than previously
thought and that extensive behavioral training may actually increase PV
expression within the rat brain.

Septotemporal differences in hippocampal PV expression are agedependent

It is well-known that the hippocampus is integral for cognitive processing
and memory formation within the brain (Milner et al., 1998). The hippocampus
can be sub-divided along its areal or longitudinal axis into: septal,
midseptotemporal, and temporal levels (Amaral & Witter, 1989). These
septotemporal regions are also associated with different cognitive, emotional,
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and behavioral information processing. Generally speaking, septal regions of the
hippocampus receive spatial information in addition to sensory information from
the neocortex, while temporal hippocampus favors emotionally salient
information processing, due to its increased amygdala input (Bannerman et al.,
2004.) Because of these distinct differences in information processing within this
structure, it follows that there would also be anatomical markers that vary parallel
to functional variation across the septotemporal axis (Gusev et al., 2005; Jinno,
2011).
In the current study, we found clear septotemporal variations in PV
immunoreactivity within the hippocampal formation of 6-month old behaviorally
naïve rats. Specifically, there was a significant difference in PV expression from
septal to midseptotemporal CA1 and DG, with septal areas exhibiting significantly
more PV expression than midseptotemporal areas. Conversely, there were no
differences in expression between midseptotemporal and temporal CA1
locations. However, this pattern was not observed in the CA3 region of 6-month
old rats, nor were there any septotemporal differences in any region for 1- month
old naïve and 24-month old behaviorally trained groups. The lack of
septotemporal difference within the CA3 region in 6-month old rats suggests the
possibility that PV expressing neurons in this region may be more resilient to
aging, while CA1 and DG regions may have increased susceptibility to the
adverse effects of aging. However, these findings may also indicate a dynamic
interaction between aging and septotemporal location within the hippocampus as
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well. To our knowledge, this is the first systematic characterization of
septotemporal variation in PV expression across distinct age groups.
Previous findings from Nomura and colleagues (1997a) indicate no
significant septotemporal variation in PV expression; however, their work was
conducted in 5 week old rats (approx.1 month of age) and therefore is in
agreement with the lack of septotemporal effect seen in the 1-month old naïve
rats in the current study. Conversely, in mouse brains processed to visualize
parvalbumin-positive interneurons, research has shown significant dorsal-ventral
differences in parvalbumin expression, particularly within stratum pyramidale
(Jinno & Kosaka, 2006). More specifically, Jinno and Kosaka (2006) provide
evidence of elevated levels of PV expression within CA1 compared to CA3 and
DG, which is in agreement with evidence presented in the current study for 6
month old rats.
It is difficult to interpret the lack of septotemporal variation in PV
expression within the hippocampus of 24-month old behaviorally trained rats.
This is primarily due to the fact that this was the only group that received
extensive behavioral training and it is possible that the training influenced the
amount of PV expression throughout the brain, including those areas examined
presently. Conversely, it is also possible that there is an age-dependent
decrease, then subsequent increase, in PV expression. Either way, these results
shed light on the dynamic properties of PV protein expression across the
hippocampus.
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Age-dependent decline in PV expression within the rat hippocampus

Our data provide support for a growing body of evidence describing an
age-dependent decline in PV expression within the hippocampus. Work by
Nomura and colleagues (1997a) indicate a high degree of PV expression within
young (5 week old) rats that is in line with our findings in 1 month old rats of high
levels of PV expression coinciding with a lack of septotemporal gradient.
However, we observed a significant decline in PV expression as a result of age in
CA1 and DG from 1-month to 6-month experimentally naïve rats, suggesting that
expression may be developmentally dynamic. These findings are in agreement
with previous studies reporting age-related decreases in PV expression within
the hippocampus (Kuruba et al., 2011; Lolova & Davidoff, 1992). Importantly, our
data argues against previous research indicating an absence of age-related
decline (e.g. Kishimoto et al., 1998) or the presence of age-related increases
(Choi et al., 2010) in hippocampal and cortical PV expression. Furthermore, the
lack of age-dependent effects of PV immunoreactivity in CA3 suggest the
possibility that age-related decline in PV expression may be regionally dependent
within the rat.
Data from 24-month old rats was not included in the aging analysis
because of the anomalous findings which may be a result of the extensive
behavioral training these rats received over their lifetime. Generally, 24-month
extensively trained rats exhibited equal (if not more) PV expression in
comparison to 1-month old rats across all hippocampal sub-regions (Figure 14),
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as well as cortical regions (Figure 10). In addition, 24-month old rats had
significantly higher PV expression in all hippocampal sub-regions and cortical
regions (with the exception of no significant difference in septal CA3, though a
clear trend was present; Figure 14). While we provide evidence against an agerelated loss of PV immunoreactivity in 24 month old rats, we cannot claim that
this is an expected and normative finding in aged rat hippocampus. In fact, in
light of the age-related decline in PV expression from 1- to 6-month old naïve
rats, we suggest that these findings are an artifact of the extensive behavioral
training this group received. Furthermore, we hypothesize that, if these animals
had not received a lifetime of behavioral training, their PV expression profile
would be that seen currently in the 6-month old naïve rats, if not further
decreased, providing strong evidence for PV decrease across the lifespan (see
Figure 15 for a proposed timeline of PV expression).

Possible role of extensive training/enrichment in increasing overall
PV expression

The prominently high levels of PV expression within all regions of interest
in 24-month old extensively trained rats in the present study were surprising and
unexpected. While we initially set out to characterize possible age- and
regionally-dependent differences in PV expression, we observed consistently
elevated expression both within the hippocampal regions (Figure 14), as well as
the cortical regions (Figure 10) examined. It is unlikely that these findings are a
result of an age-dependent shift in PV immunoreactivity, but rather suggest a

27

dynamic interaction between the expression of this particular calcium-binding
protein within the brain and the behavioral experiences of the animal.
Experience-related changes in the expression of neuronal and cellular
markers (e.g., BrdU, NeuN, BDNF, apoptotic markers, etc.) are a wellestablished phenomenon in the literature (van Praag et al., 2000). A multitude of
experiences have the capability of altering brain structure and function, including
(but certainly not limited to): maze training (Van der Borght et al., 2005), social
interaction (Woolley & Doupe, 2008); physical stimulation (e.g. stimulation of
whiskers; Knott et al., 2002); sexual experience (Leuner et al., 2010); stress
(Zoladz et al., 2012); and, a topic of extensive research, environmental
enrichment (Harati et al., 2011). There are few studies which have examined the
effects of enrichment specifically with regard to PV, but those that have been
reported indicate enrichment and/or deprivation-related alterations within sensory
cortices (Jiao et al., 2006), striatum (De Bartolo et al., 2011), and hippocampus
(Iuvone et al., 1996). The findings by Iuvone and colleagues (1996) provide
evidence of experience-related increases in PV expression, specifically within the
hippocampal regions CA1, CA3, and DG, which is consistent with our findings in
24-month old rats, and suggests that this finding is likely an artifact of
enrichment, and not an age-related effect.

General Discussion

Overall, we present evidence in support of age-related decreases in PVexpressing GABAergic interneurons within CA1 and DG regions of the
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hippocampus from 1- to 6-month old naïve rats, as well as regionally-specific
expression in CA1 compared to CA3 and DG across three distinct age groups.
We also provide compelling evidence for a dynamic interaction between PV
protein expression within the hippocampus and neocortical regions and life-long
enrichment in the form of extensive behavioral training. The present findings
provide a framework to inform future studies. Specifically, the regional and agerelated differences seen here as a result of age can allow for future experiments
seeking to understand the effects of pharmaceutical agents (e.g. NMDAantagonists), such that they can ensure proper controls, and therefore provide
more compelling evidence for differences in neuronal markers. Additionally, the
results seen in extensively trained animals open up a new avenue of research,
and could possibly inform preventative studies of psychopathologies. Though
preliminary in nature, these data provide straightforward evidence for age- and
experientially-dependent influences on the expression of PV in rat hippocampus
and nearby sensory cortices.
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Chapter Three: Discussion
The current study provides support for past research indicating an agedependent decrease in PV expression within the hippocampus of rats (e.g. Vela
et al., 2003). Furthermore, it provides new and compelling evidence for an agedependent decline in PV expression across the septotemporal axis, which, to our
knowledge, has not been previously reported. We found evidence indicating
elevated PV expression within the hippocampal CA1 sub-region, compared to
CA3 and DG regions, across all age-groups, and a general lack of differences
within the CA3 sub-region across age and septotemporal location. Of particular
interest, we describe possible experientially-dependent effects on PV expression,
indicating that PV has dynamic expression, and can likely be differentially
affected by a variety of environmental and biological phenomena. The current
study is the first of its kind in systematically characterizing PV expression not
only across the septotemporal axis of the hippocampus, but also across diverse
age groups in rats, and provides critical baseline data describing PV expression
within key brain regions implicated in psychopathology.

Contributions of the current work to the literature: Age-related
changes in PV expression
Previous work detailing the distribution of PV expression within the rodent
hippocampus and other cortical areas has been important to our understanding
of their role in interneuronal circuits. For instance, Nomura and colleagues
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(1997a) characterized PV expression across the septotemporal axis of the
hippocampus, and indicated no differences in PV expression based on
septotemporal level. These findings perpetuate the notion that PV expression is a
static marker in GABAergic interneurons within the normal, untreated brain.
However, this study lacks generalizability across age groups, as their analyses
were only performed in young rats (5 weeks of age). This is problematic for a
variety of reasons, but particularly so because many experimental studies (e.g.
those using NMDA-antagonist treatments) do not control for age, and baseline
data for PV expression across age-groups is needed for comparison and
accurate interpretation of results.
An overwhelming degree of inconsistency is seen in the reports of PV
immunoreactivity following acute and/or chronic administration of NMDAantagonist drugs (e.g. ketamine; MK-801). We believe that many of these
inconsistencies are likely a result of a failure to control for age in the rodent
models utilized, and that their questions may be better answered if they were
aware of the dynamic changes seen in PV expression as a consequence of age.
For example, studies that have seen no significant changes in PV expression,
especially in the hippocampus, following NMDA-antagonist administration
regimens have used rodents aged PD7 (Wang et al., 2008), 1 month of age
(Zhang et al., 2008), PD 20 & 40 (Stuellet et al., 2010); and 3 months of age
(Benneyworth et al., 2011). Note, that all of these studies, which have found no
significant impact of NMDA-antagonism on PV expression, have not only used a
wide variety of ages across studies, but all of these animals have generally been
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3 months of age or less. According to our findings, 1 month old rats appear to
have very high expression of PV across all regions studied, and this expression
is likely robust and resistant to change in young animals.
Conversely, studies conducted administering NMDA-antagonist drugs in
rats 4 months of age and older, observed significant decreases in PV expression
within the hippocampal formation (Stuellet et al., 2010; Keilhoff et al., 2004), as
well as within the prefrontal cortex (Romon et al., 2011). This disparity is
compelling, as it suggests that there may be an age-dependent response to
NMDA-antagonist drugs, making adult rodents more susceptible to PV loss as a
result of administration of these substances. This could perhaps indicate a
decreased stability in the expression of PV in adulthood or, more simply, that PV
is a dynamic protein that has the ability to constantly up- or down-regulate its
expression with the age and needs of the animal. To make this argument more
compelling, studies should be conducted in aged rats (1+ years) in these NMDAantagonist models to determine whether a similar pattern to adult PV loss is
seen, or if perhaps PV decreases are limited to a window of susceptibility, much
like what is seen for schizophrenic onset in humans (e.g. Gogtay et al., 2011;
Castle et al., 1998). Overall, the current work sheds light on the need for
considering age in rodent models of psychiatric disorders to account for the
dynamic expression of neuronal markers (e.g. PV) throughout the lifespan.
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Contributions of the current work to the literature: Experiencerelated changes in PV expression
Here we describe a new and intriguing phenomenon of experienceinduced increases in PV expression in aged (24-month old) rats. To our
knowledge, this is the first report of increased PV in aged rats as a result of
extensive life-long behavioral training. While previous studies have observed
increases in PV as a result of experience, these results are limited, and generally
encompass young animals. For example, reports of increased PV expression
within the brain have been attributed to enrichment-related events such as:
neonatal auditory stimulation (Chaudhury et al., 2008); increased neural activity
in visual cortex (Patz et al., 2004); univibrissa rearing (Nowicka et al., 2009); and
adolescent exercise (Gomes da Silva et al., 2010), among others. Furthermore,
sensory deprivation in young rodents has been shown to down-regulate PV
expression (e.g. Jiao et al. 2006).
Interestingly, a study by Siucinska and Kossut (2006) reports no difference
in PV expression in the barrel cortex as a result of short-term sensory learning in
adult mice. This is contradictory to our findings of experience-related increases in
PV expression within the barrel cortex in 24-month old rats. However, Siucinska
and Kossut looked at the effects of short-term sensory learning, while our effect
is driven by extensive, life-long behavioral training and experience. Though
younger animals seem to have a greater benefit of experience on PV expression,
it may be the case that adult and aged animals need more extensive experience
in order for it to manifest with increased PV expression. Our data provide
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descriptive and quantitative evidence for an up-regulation of PV expression
following extensive behavioral training, and can be taken as evidence for the
dynamic nature of PV expression across the lifespan, and when faced with
different short- or long-term experiences.

Future Directions
While preliminary in nature, the current study has provided us with novel
and informative data to move forward with on-going studies in our lab to
understand anatomical consequences of chronic NMDA antagonist treatment.
Furthermore, the baseline data we have collected through this study provide a
starting point for more in-depth future studies to more thoroughly characterize the
dynamic nature of PV expression across the lifespan. Of particular note, the data
indicating a significant increase in PV expression in extensively trained aged rats
has provided rationale for a new avenue of research describing enrichmentinduced changes in calcium-binding protein expression.

Expanding upon observed age-dependent changes in PV expression

While the current study provides a starting point for more thorough
research into age-related differences in PV expression throughout the rodent
brain, there is still much to be done. To our knowledge, there are not studies
which have systematically explored PV expression across multiple brain regions
as a function of age, and particularly those that look at rats over 1.5 years of age
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in comparison to postnatal and adult rats. Such characterization would not only
be beneficial to the overall understanding of PV distribution within the rodent
brain, but would provide reliable baseline data from which to base future studies
aiming to observe PV expression as a meaningful marker of pathology.
In an attempt to further understand the effect of age on PV expression, it
would be useful to conduct a series of studies looking at multiple ages of rats
including: postnatal pups, young (e.g. 1-3months), young adults (e.g. 6 months),
adult (e.g. 1 year) and aged (e.g. 2 years) in order to describe the dynamics of
PV expression as a function of age. Furthermore, within each age group multiple
brain regions should systematically examined including: hippocampal subregions (CA1, CA3, DG, subiculum), somatosensory cortices, limbic cortices, as
well as other regions known to have high expression of PV (e.g. cerebellum; De
Bartolo et al., 2011). Such an anatomical characterization of PV distribution
would add depth to previous studies which have attempted to provide
comprehensive understanding of PV distribution, but did not account for age and
had a more narrow anatomical focus (e.g. Nomura et al., 1997a; 1997b).

Expanding upon observed enrichment-dependent changes in PV
expression

We are especially interested in following up on the enrichment-induced
changes observed in the 24-month old rats in the present study. As this is the
first report of extensive training resulting in a substantial increase in PV
expression (back to levels seen in 1-month old naïve rats and sometimes even
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significantly higher), follow-up work is required to validate these results in a more
controlled manner. Specifically, we propose to more closely examine the role of
enrichment across the rat lifespan to determine 1) whether PV expression is, as
is suggest in the present body of work, age-dependent in naïve rats; 2) whether
septotemporal variation in PV is age-dependent, as our data imply; 3) whether
behavioral experience (in the form of extensive radial water maze training)
significantly increases PV expression throughout hippocampus and other areas
of the brain (e.g. somatosensory and limbic cortices); and 4) whether an
interaction exists between age and experience to differentially modify PV
expression in the rat brain. We hypothesize that in naïve rats a significant agedependent decrease in PV expression would be evident, and that rats receiving
extensive training would have no age-dependent decrease in PV expression
compared to their naïve counterparts; findings which would be consistent with the
data presented in the current study.
Due to the wide use of decreased PV expression as a marker in animal
models of schizophrenia (e.g. Kittelberger et al., 2012; Benneyworth et all, 2011),
our lab is also interested in the effects of NMDA-antagonism (ketamine) on PV
expression and memory as a function of age, as well as experience. Within the
radial water maze paradigm (described in Chrobak et al., 2008), we suspect that
ketamine-induced memory deficits in the radial water maze may be mirrored by a
concomitant decrease in PV expression. Furthermore, since these animals will
have had extensive training, and therefore increased PV expression, we believe
that any ketamine-induced changes in expression would be clearly evident. In
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fact, decreases in PV expression in ketamine-treated behaviorally trained rats
are hypothesized to have similar, if not the same amount, of PV expression as
their aged experimentally naïve counterparts. Such findings would provide
compelling evidence of PV as a dynamic and fluctuating biological marker that
has the ability to be influenced by biological, pharmacological, and environmental
factors. Furthermore, these proposed findings would also provide validity to
previous studies which have observed NMDA-antagonist induced decreases in
PV expression (e.g. Kittelberger et al., 2012) and perhaps even offer explanatory
evidence for why other studies failed to see a decrease as a result of NMDAantagonist administration due to their sole use of young rats (e.g. Benneyworth et
al., 2011).

General Conclusions
Overall, the current body of work has provided a solid foundation for future
work describing age-related and septotemporal changes in PV expression in
rodents. Additionally, it has opened up a new avenue of research into the
dynamic properties of the calcium-binding protein, PV, and its modulation by
behavioral training and enrichment. Though preliminary, our findings provide
promising evidence for age- and experientially-dependent changes in PV
expression with key brain regions associated with cognitive function. Importantly,
the current findings of our study, and those we have proposed, will allow for
better understanding, and interpretation, of future studies, especially with regard
to modeling schizophrenic cognitive dysfunction.
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Figures

Figure 1: Location of representative sections relative to Bregma.
PV-stained sections were pseudo-randomly selected for analysis of PV
expression across the long axis of the hippocampus, somatosensory cortex, and
retrosplenial cortex. Representative Nissl sections were used to help delineate
areas and can be seen in this figure. Septal CA1, CA3, and DG samples, as well
as retrosplenial and somatosensory (barrel field) cortex samples, were taken
from sections within -2.45mm through -3.9mm relative to Bregma (A).
Midseptotemporal CA1, CA3, and DG, in addition to temporal CA1 and CA3,
samples were taken from sections within -5.0mm through -6.0mm relative to
Bregma (B).Sampled sections were roughly 240µm apart from one another.
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Figure 2:Optimizing PV Antibody Concentration for Visualization of PVcontaining Interneurons.
In order to determine the optimal anti-parvalbumin antibody concentration, a
subset of rats (n = 2) were used to compare three different concentrations:
1:1000 (A), 1:4000 (B), and 1:7000 (C). Based on qualitative observations, it was
determined that an antibody concentration of 1:4000 was optimal for the purpose
of visualizing PV expression for the current study. As evident in A, 1:1000
produced a high amount of background staining making it difficult to distinguish
PV-expressing cell bodies. In contrast in C, a concentration of 1:7000 resulted in
very light staining, making it difficult to distinguish whether some of the possible
expression was, indeed, PV-expressing cells or simply staining artifacts.
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Figure 3: Anatomical locations of photomicrographs taken for analysis of PV
expression in hippocampal regions of interest.
Photomicrographs of septal hippocampal sub-regions were taken between areas
were taken between -2.45mm through 3.9mm relative to Bregma (A), while
midseptotemporal and temporal sections were taken between -5mm through 5mm relative to Bregma (B). Septal hippocampal photomicrographs of CA1
(A.1), CA3 (A.2), and DG (A.3) were taken at 20x magnification.
Midseptotemporal CA1 (B.1), CA3 (B.2), and DG (B.3), as well as temporal CA1
(B.4) and CA3 (B.5) were also taken at 20x magnification. Photomicrographs of
all regions were taken within the boxed regions of interest as outlined above.
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Figure 4: Example of PV-expressing interneuron quantification using ImageJ
color-based thresholding.
Cell counting was automized using ImageJ and region-specific macros in order to
ensure unbiased, consistent quantification within each area of interest. An
example of threshold-based quantification, in this case from hippocampal CA1,
can be seen above. The first panel shows an original photomicrograph of CA1
with PV-expressing interneurons clearly evident, particularly within the pyramidal
cell layer. The second panel shows the same photomicrograph, thresholded
based on color density to isolate the most darkly stained cells. A macro was then
run to count the number of PV-expressing cells based on previously set
parameters and exclude any thresholded particles (e.g. non-cell artifacts) that do
not meet criteria for inclusion (e.g. size, sphericity), and provided an output
identifying the counted cells (as can be seen in the third panel).
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Figure 5: Septotemporal differences in PV expression as a function of
hippocampal sub-region and age.
6-month old rats had significant septotemporal variation in PV expression within
hippocampal CA1 (A) and DG (B), but not in CA3 (C). The most striking
difference in 6-month old rats were the decreases from septal to
midseptotemporal, however, there was no difference between midseptotemporal
and temporal CA1 in 6-month old rats (A).There was no effect of septotemporal
location in 1- and 24-month old rats in any hippocampal sub-region (A-C).
* p < .05
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Figure 6: Distribution of HPC CA1 PV+ interneurons as a function of age and
septotemporal location.
Representative photomicrographs of hippocampal CA1 PV expression across
age and septotemporal location. A clear age-related decline in PV-expression
from 1- to 6-month old naïve rats in midseptotemporal and temporal CA1 can be
seen even through qualitative comparison. 24-month old extensively trained rats
have comparatively higher PV expression across all septotemporal levels of CA1.
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Figure 7: Distribution of HPC CA3 PV+ interneurons as a function of age and
septotemporal location.
Representative photomicrographs of hippocampal CA3 PV expression across
age and septotemporal locations. There were no significant age-related declines
in PV expression within any septotemporal level of CA3.
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Figure 8: Distribution of HPC DG PV+ interneurons as a function of age and
septotemporal location.
Representative photomicrographs of hippocampal DG PV expression across age
and septotemporal location. From simple observation, it is clear that there are far
more PV+ interneurons in extensively trained 24-month old DG. Furthermore, it is
evident that there is a significant age-related decline in PV expression from 1- to
6-month old naïve rats.
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Figure 9: Age-dependent decrease in parvalbumin expression within the
hippocampal sub-regions CA1 and DG, but not CA3.
Within CA1 (A) there is a significant age-related decrease in PV expression from
1- to 6-month old rats in midseptotemporal and temporal locations. This agerelated decline in PV expression is also seen in septal and midseptotemporal DG
(B). There is no noncommittal decrease in PV expression in any septotemporal
region in hippocampal CA3 (C). These data suggest that PV expression
decreases within CA1 and DG as age increases. *p < .05
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Figure 10: 24-month-old rats have significantly higher PV+ cells within
retrosplenial and somatosensory cortices than 1- and 6-month-old rats.
Photomicrographs of the cortical regions of interest were taken from -2.45mm
through -3.9mm relative to Bregma, with retrosplenial cortical photos taken at 20x
magnification (A.1), and somatosensory (barrel field) cortical photos taken at 10x
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magnification to ensure visualization of all cortical lamina (A.2). 24-month old
extensively trained rats had significantly higher PV+ cells within the retrosplenial
cortex (B) and somatosensory cortex (C) than both 1- and 6-month old rats.
There was no statistically significant difference between PV expression within
these cortices between 1- and 6-month old experimentally naïve rats. These
findings suggest that extensive training increases PV+ expression within these
cortical regions. *p < .01
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Figure 11: PV+ expression within the retrosplenial cortex across age groups.
As shown statistically in Figure 10B, it is clear through visual observation that 24month old extensively trained rats (C) have significantly more PV expression
within the retrosplenial cortex than 1- (A) and 6- (B) month old naïve rats.
Though there was no statistically different expression between 1 and 6 month old
rats, the PV+ interneurons in 1 month old rats (A) appear visually larger than
both 6 and 24 month old rats. It is unknown why, though this observation could
be due to larger cell size in young rats, or perhaps an increase in PV expression.
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Figure 12: PV+ expression within the somatosensory (barrel field) cortex:
distribution depends on age.
Qualitative observations within the somatosensory cortex barrel fields revealed
an age-dependent distribution of PV expression across cortical layers. The top
panels (A-C) show full photomicrographs of the barrel field cortex for 1 (A), 6 (B),
and 24 (C) month old rats. It is clear that 24 month old extensively trained rats
have significantly more PV+ interneurons than both 1 and 6 month old naïve rats.
Bottom panels (D-F) show higher magnification of top panels to illustrate laminar
differences in PV distribution based on age of the animal. 1 month old rats have
PV expression almost exclusively in the deep cortical layers (D), while 6 month
(E) old rats (while having statistically similar overall expression to 1 month old
rats) have PV expression in both deep and artificial cortical layers (but not in
layers 3/4). In contrast, 24 month old rats show PV expression in all cortical
layers containing cell bodies (F).
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Figure 13: Hippocampal CA1 has significantly more PV expression than CA3
and DG in septal and midseptotemporal regions across all age groups.
Across all age groups (1-, 6-, and 24-months), regardless of past experience,
CA1 PV expression was significantly higher in septal and midseptotemporal
levels when compared to CA3 and DG (A-C). Interestingly, in 24-month old
extensively trained rats (C) there was no difference between CA1 and CA3 at the
midseptotemporal level, though the DG had significantly lower PV expression
than either CA1 or CA3. There was no difference between PV expression in
temporal locations between CA1 and CA3 regions. *p < .05
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Figure 14: 24-month old extensively trained rats have elevated PV expression
across all hippocampal regions.
In CA1 and CA3, there were no septotemporal differences in PV expression in
24-month old rats; however, there was a significant decrease in PV expression
between septal and midseptotemporal DG (A). Within CA1 (B), 24-month old
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extensively trained rats had significantly higher PV expression than 6-month old
naïve rats at all septotemporal levels. Furthermore, 24-month old rats had
significantly higher PV expression than 1-month old rats in septal CA1, though
there were no differences between the two groups in midseptotemporal or
temporal CA1. Within the DG (C), 1- and 24-month old rats had significantly
higher PV expression than 6-month old rats in septal CA1. There were no
differences between 1- and 24-month old rats at either level, and no difference
between 1- and 6-month old rats in midseptotemporal DG, though a significant
difference between 6- and 24-month old rats was seen in this region. 24-month
old rats had significantly higher PV expression than both 1- and 6-month old rats
in midseptotemporal and temporal CA3 regions (D). No differences were seen
between age-groups in septal CA3. *p < .05
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Figure 15: Proposed age-dependent decline in PV expression as a function of
brain region.
Here, we propose a theoretical framework for PV expression as a function of age
and brain region. These are approximations based on the data collected in the
present study, and reflect an age-dependent decline in PV expression that
continues with age, as is seen in the 1-month to 6-month decrease in
hippocampal, but not cortical, areas. We propose that over the course of the
lifespan, hippocampal regions (especially CA1 and DG, based on our results)
would be most impacted, and CA3 would be minimally impacted, while
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neocortical regions would remain relatively stable over the lifespan. Circles
indicate observations seen in 24-month old behaviorally trained rats in the
current study, while dotted lines indicate proposed levels of PV expression we
would expect to see in naïve aged rats.

68

Tables
Table 1. Average number of parvalbumin-positive interneurons across cortical
and hippocampal regions in the rat brain as a function of age and septotemporal
location.

Cortex
Retrosplenial a
Barrel Field b

1 month
M±SEM

n

6 months
M±SEM

n

24 months
M±SEM

n

50.4±8.2
73.5±18.1

8
8

41.5±10.7
105.4±22.0

8
8

95.2±21.0
250.9±31.8

8
8

Hippocampusc
CA1

Septal
Midseptotemporal
Temporal

15.6±2.2
12.0±1.3
13.5±2.4

8
8
7

12.1±1.7
5.9±1.3
4.3±0.9

8
8
8

19.6±2.1
15.6±2.3
17.1±1.4

8
8
8

CA3

Septal
Midseptotemporal
Temporal

6.9±1.5
3.7±1.4
8.6±0.9

8
6
6

3.2±1.6
2.9±1.1
6.9±1.9

8
8
8

9.9±2.4
11.8±1.2
14.8±1.2

8
8
8

DG Septal
Midseptotemporal

5.0±0.5
2.4±1.0

8
6

0.6±0.3
0.3±0.2

8
8

6.8±1.5
3.6±1.2

8
8

a

analyzed region was 1600µm x 1000µm

b

analyzed region was 800µm²

c

analyzed region was 800µm x 500µm
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